Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111869810> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W3111869810 abstract "To investigate the relationship between microaneurysm (MA) density and residual oedema after intravitreal injection of an anti-vascular endothelial growth factor agent for the treatment of diabetic macular oedema (DMO).Patients with DMO were divided into those with residual oedema (RO) and those with no residual oedema (NRO) by the presence and absence of oedema at 1 month after intravitreal injection of either aflibercept or ranibizumab. We then compared MA density, best corrected visual acuity (BCVA), central retinal thickness (CRT) and size of the severely thickened area, as indicated by a white area (WA) on optical coherence tomography.We examined 48 eyes in the RO group and 25 eyes in the NRO group (n = 73). In both groups, the CRT and WA size significantly decreased and BCVA improved at 1 month and thereafter. CRT was significantly higher and BCVA was poor in the RO group at 1 and 3 months, while WA size was larger at 1, 3 and 6 months compared with the NRO group (p < 0.05). The number of injections in the RO group (3.62 ± 1.75) was larger than the NRO group (1.89 ± 0.97; p < 0.0001). At 1 and 6 months, the MA density in the area with persistent oedema was significantly higher than in the area with improved oedema (1 month: p = 0.0001, 6 months: p = 0.029).High MA density and extensive swelling may be characteristic of RO following treatment for DMO with intravitreal injection of either aflibercept or ranibizumab." @default.
- W3111869810 created "2020-12-21" @default.
- W3111869810 creator A5010631611 @default.
- W3111869810 creator A5012578042 @default.
- W3111869810 creator A5036049347 @default.
- W3111869810 creator A5039891391 @default.
- W3111869810 creator A5086330133 @default.
- W3111869810 creator A5091809447 @default.
- W3111869810 date "2020-12-16" @default.
- W3111869810 modified "2023-10-18" @default.
- W3111869810 title "Microaneurysm density in residual oedema after anti‐vascular endothelial growth factor therapy for diabetic macular oedema" @default.
- W3111869810 cites W1545259384 @default.
- W3111869810 cites W1997904186 @default.
- W3111869810 cites W2005409914 @default.
- W3111869810 cites W2049036672 @default.
- W3111869810 cites W2123123877 @default.
- W3111869810 cites W2161279821 @default.
- W3111869810 cites W2277114402 @default.
- W3111869810 cites W2289200040 @default.
- W3111869810 cites W2324588265 @default.
- W3111869810 cites W2468757992 @default.
- W3111869810 cites W2509900411 @default.
- W3111869810 cites W2528314549 @default.
- W3111869810 cites W2531280297 @default.
- W3111869810 cites W2601652796 @default.
- W3111869810 cites W2616361514 @default.
- W3111869810 cites W2737633239 @default.
- W3111869810 cites W2790351317 @default.
- W3111869810 cites W2793053364 @default.
- W3111869810 cites W2890357764 @default.
- W3111869810 cites W3022719814 @default.
- W3111869810 cites W3034475198 @default.
- W3111869810 cites W4244626725 @default.
- W3111869810 cites W922383587 @default.
- W3111869810 doi "https://doi.org/10.1111/aos.14706" @default.
- W3111869810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33326191" @default.
- W3111869810 hasPublicationYear "2020" @default.
- W3111869810 type Work @default.
- W3111869810 sameAs 3111869810 @default.
- W3111869810 citedByCount "4" @default.
- W3111869810 countsByYear W31118698102021 @default.
- W3111869810 countsByYear W31118698102022 @default.
- W3111869810 countsByYear W31118698102023 @default.
- W3111869810 crossrefType "journal-article" @default.
- W3111869810 hasAuthorship W3111869810A5010631611 @default.
- W3111869810 hasAuthorship W3111869810A5012578042 @default.
- W3111869810 hasAuthorship W3111869810A5036049347 @default.
- W3111869810 hasAuthorship W3111869810A5039891391 @default.
- W3111869810 hasAuthorship W3111869810A5086330133 @default.
- W3111869810 hasAuthorship W3111869810A5091809447 @default.
- W3111869810 hasBestOaLocation W31118698101 @default.
- W3111869810 hasConcept C118487528 @default.
- W3111869810 hasConcept C141071460 @default.
- W3111869810 hasConcept C2776694085 @default.
- W3111869810 hasConcept C2777802072 @default.
- W3111869810 hasConcept C2778257484 @default.
- W3111869810 hasConcept C2778749236 @default.
- W3111869810 hasConcept C2780827179 @default.
- W3111869810 hasConcept C2781100027 @default.
- W3111869810 hasConcept C71924100 @default.
- W3111869810 hasConceptScore W3111869810C118487528 @default.
- W3111869810 hasConceptScore W3111869810C141071460 @default.
- W3111869810 hasConceptScore W3111869810C2776694085 @default.
- W3111869810 hasConceptScore W3111869810C2777802072 @default.
- W3111869810 hasConceptScore W3111869810C2778257484 @default.
- W3111869810 hasConceptScore W3111869810C2778749236 @default.
- W3111869810 hasConceptScore W3111869810C2780827179 @default.
- W3111869810 hasConceptScore W3111869810C2781100027 @default.
- W3111869810 hasConceptScore W3111869810C71924100 @default.
- W3111869810 hasIssue "6" @default.
- W3111869810 hasLocation W31118698101 @default.
- W3111869810 hasLocation W31118698102 @default.
- W3111869810 hasOpenAccess W3111869810 @default.
- W3111869810 hasPrimaryLocation W31118698101 @default.
- W3111869810 hasRelatedWork W1990147459 @default.
- W3111869810 hasRelatedWork W2050270337 @default.
- W3111869810 hasRelatedWork W2123096760 @default.
- W3111869810 hasRelatedWork W2553987180 @default.
- W3111869810 hasRelatedWork W2577193304 @default.
- W3111869810 hasRelatedWork W2605504011 @default.
- W3111869810 hasRelatedWork W2981977889 @default.
- W3111869810 hasRelatedWork W3124858697 @default.
- W3111869810 hasRelatedWork W3179839195 @default.
- W3111869810 hasRelatedWork W4243304339 @default.
- W3111869810 hasVolume "99" @default.
- W3111869810 isParatext "false" @default.
- W3111869810 isRetracted "false" @default.
- W3111869810 magId "3111869810" @default.
- W3111869810 workType "article" @default.